Association of Surgical Treatment with Survival in Patients with Prosthetic Valve Endocarditis.
Prosthetic valve endocarditis (PVE) is a serious condition with high morbidity and mortality. This study investigated the association of surgical treatment with survival among patients with PVE. A retrospective cohort study was done of patients with PVE hospitalized over 8 years in a large referral center. Association of surgery with survival was evaluated using multivariable Cox proportional hazards regression, adjusting for propensity to be accepted for surgery, and analyzing surgery as a time-dependent covariate. Survival was also compared separately in a 1:1 propensity score-matched cohort of patients accepted for surgery and controls consigned to non-surgical treatment. Of 523 patients (mean [SD] age 61 [14] years, 370 [71%] males, 393 [75%] initially accepted for surgery), 404 ultimately underwent surgery and 119 received non-surgical treatment alone. Surgical treatment was associated with significantly lower hazard of death in the entire cohort (HR 0.32, 95% CI 0.22 to 0.48, P <0.001) and in the 1:1 matched cohort (HR 0.33, 95% CI 0.19 to 0.57, P < 0.001). Initial acceptance for surgery was associated with significantly lower odds of in-hospital death (OR 0.26, 95% CI 0.11 to 0.59, P <0.001), death or readmission within 90 days (OR 0.17, 95% CI 0.07 to 0.43, P <0.001), and death within one year (OR 0.16, 95% CI 0.08 to 0.34, P <0.001). Surgical treatment is associated with a large survival benefit in PVE. A decision to pursue non-surgical treatment in PVE should entail very close follow-up for any development of an indication for surgery.